Specific Inhibition of GSK-3β by Tideglusib: Potential Therapeutic Target for Neuroblastoma Cancer Stem Cells
H. F. Bahmad, R. M. Chalhoub, H. Harati, J. Bou-Gharios, F. Ballout, A. Monzer, H. Msheik, S. Assi, T. Araji, M. K. Elajami, P. Ghanem, F. Chamaa, H. Kadara, T. Abou-Antoun, G. Daoud, , W. Abou-Kheir
This study evaluates Tideglusib's effectiveness in inhibiting neuroblastoma cell proliferation, viability, migration, and CSC self-renewal both in vitro and in vivo.
bioRxiv · Feb 18, 2020 · PreprintCancer Biology